Principal Accounting Officer · Summit Therapeutics Inc. (SMMT)

Jeffrey Maranian

FY2021 is the first fiscal year CompBrief holds for Jeffrey Maranian as a named executive officer of Summit Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,044,147

Salary $289,583Stock awards $0

3rd of 3 named executive officers at Summit Therapeutics by FY2021 total.

4 named officers on file for Summit Therapeutics, FY2021

Jeffrey Maranian’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Summit Therapeutics’s whole pay program stands against its peers

  • Summit Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SMMT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Jeffrey Maranian’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jeffrey Maranian compensation by year

Summit Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Summit Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$289,583
Bonus$0
Stock awards$0
Option awards$707,087
Non-equity incentive$0
Pension and deferred compensation$0
All other$47,477
Total$1,044,147

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Therapeutics Inc. DEF 14A filed April 29, 2022, accession 0001599298-22-000037, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Summit Therapeutics Inc. filed document, accession 0001599298-22-000037. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

Summit Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Mahkam ZanganehDirector and Chief Operations Officer$9,639,214
David PowellFormer Chief Scientific Officer$1,606,698
Jeffrey Maranian · this pagePrincipal Accounting Officer$1,044,147
Robert DugganChief Executive Officer and Executive Chairman—

The full Summit Therapeutics compensation record

free company brief

This page is one person within Summit Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Summit Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jeffrey Maranian's compensation dossier · One-time report. No refunds.